Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$7.81M |
| 2 |
Dollar General
DG
|
+$4.13M |
| 3 |
Keurig Dr Pepper
KDP
|
+$3.85M |
| 4 |
General Motors
GM
|
+$2.97M |
| 5 |
Accenture
ACN
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$2.95M |
| 2 |
Amazon
AMZN
|
+$2.87M |
| 3 |
Zimmer Biomet
ZBH
|
+$2.61M |
| 4 |
JPMorgan Chase
JPM
|
+$2.31M |
| 5 |
Intel
INTC
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.58% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 11.3% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.81% |
Similar funds
Stoneridge Investment Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Stoneridge Investment Partners held 120 positions worth $230M, up 22% from $189M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Stoneridge Investment Partners deployed $28.7M of net new capital in Q2 2023, opening 25 new positions and adding to 59 existing holdings. Its largest new stake was CVS Health: 109,812 shares worth $7.59M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $2.87M trimmed.
- Stoneridge Investment Partners's largest Q2 2023 buy was CVS Health: 109,812 shares worth $7.59M.
- Stoneridge Investment Partners added most to Dollar General in Q2 2023, an estimated $4.13M increase.
- Stoneridge Investment Partners's biggest Q2 2023 reduction was Amazon, cutting an estimated $2.87M.
- Stoneridge Investment Partners fully exited Cigna in Q2 2023, selling an estimated $2.95M.
- Stoneridge Investment Partners's ten largest holdings make up 38% of its $230M portfolio in Q2 2023.
- Stoneridge Investment Partners opened 25 new positions and closed 13 in Q2 2023.
- Stoneridge Investment Partners's portfolio value rose 22% quarter-over-quarter to $230M.
Based on Stoneridge Investment Partners's 13F filing for Q2 2023, filed 4 Aug 2023.